编者按：第11届亚太人类遗传学大会（APCHG 2015）于 9 月 16-18 日在越南河内完美落幕。本届大会以“Genetics and Genomics: The Path to Translational Medicine”为主题，旨在为参会人员提供一个讨论人类遗传学进展的平台。本次大会上，400 份 AME 旗下 Annals of Translational Medicine（简称 ATM）杂志会议专辑，800 份 Translational Pediatrics（简称 TP）杂志两期特刊宣传页被放入会议资料包，送达到 400 余位参会人员的手中。来自美国 Genome Sciences University of Washington Medical Center Seattle 的 Prof.Gail Jarvik 作为本次大会两位 keynote speakers 之一，就“The path to genomic medicine”一题作了精彩的报告。Prof.Jarvik 会后接受了「AME 科研时间」的专访。
Today you gave an excellent speech on “The path to genomic medicine”, could you give a summary on the main points of your report?
We notice you have been working on genomic medicine for a long time. How do you see its progress during the past years?
Today you reported several impressive researches and share some stories behind. It sounds interesting and challenging. Would you like to share with us any stories with patients on your path towards genomic medicine research?
In your report, you mentioned “measuring the outcomes of genomic medicine”, would you like to specify this point?
受访专家|Prof. GAIL JARVIK M.D.,Ph.D Head, Division of Medical Genetics. The Arno G. Motulsky Endowed Chair in Medicine Professor of Genome Sciences University of Washington Medical Center Seattle, WA, USA. Professor Gail Jarvik M.D.,Ph.D is an internist and medical geneticist who holds the Arno G. Motulsky Endowed Chair in Medicine and heads the Division of Medical Ge- netics and the Northwest Institute of Genetic Medicine at the University of Washing- ton in Seattle. She cares for adult medical genetics patients. Her research focuses on the statistical genetic analysis of common diseases and the implementation of genomic medicine. Additionally, she has active research in biomedical ethics, includ- ing returning genomic research results to subjects. She is a PI in both the Electronic Medical Records and Genomics (eMERGE) and clinical sequencing exploratory re- search (CSER) consortia.